SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
1 Year Est. Return
+79.73%
AUM
$694M
AUM Growth
+$90.7M
(+15%)
Holding
89
Top Buys
| 1 | +$29.7M | |
| 2 | +$27.3M | |
| 3 | +$25.2M | |
| 4 |
Icon
ICLR
|
+$24.5M |
| 5 |
Maximus
MMS
|
+$21.8M |
Top Sells
| 1 | +$47.4M | |
| 2 | +$34.1M | |
| 3 | +$30.9M | |
| 4 |
Zimmer Biomet
ZBH
|
+$29.6M |
| 5 |
Kenvue
KVUE
|
+$25.3M |
Sector Composition
| 1 | Healthcare | 92.9% |
| 2 | Industrials | 7.1% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Maximus
MMS
$3.25B
| $49.3M | 7.1% |
768,825
+268,521
|
|
||
|
WAY
2
Waystar Holding Corp
WAY
$3.82B
| $39.6M | 5.71% |
1,642,236
+1,028,511
|
|
||
|
3
Icon
ICLR
$10.4B
| $33.9M | 4.89% |
306,358
+179,156
|
|
||
4
Cencora
COR
$52.4B
| $31.7M | 4.57% |
100,894
+84,994
|
|
||
5
Dianthus Therapeutics
DNTH
$5.08B
| $31.1M | 4.48% |
370,045
-104,458
|
|
||
|
AVR
6
Anteris Technologies
AVR
$839M
| $29.9M | 4.31% |
5,382,965
+3,508,324
|
|
||
7
Corcept Therapeutics
CORT
$7.46B
| $27.2M | 3.92% |
+674,759
|
|
||
8
LivaNova
LIVN
$4.05B
| $26.8M | 3.86% |
421,615
+99,233
|
|
||
9
Tyra Biosciences
TYRA
$1.99B
| $23.2M | 3.34% |
605,439
+79,437
|
|
||
10
Celcuity
CELC
$6.48B
| $22.1M | 3.19% |
193,843
-283,224
|
|
||
11
GSK
GSK
$101B
| $21.3M | 3.07% |
+385,879
|
|
||
12
ANI Pharmaceuticals
ANIP
$1.78B
| $20.4M | 2.94% |
265,543
+178,271
|
|
||
13
Abbott
ABT
$149B
| $19.2M | 2.76% |
+186,574
|
|
||
14
Embecta
EMBC
$201M
| $16.3M | 2.35% |
+1,847,850
|
|
||
|
ABVX
15
Abivax
ABVX
$10.6B
| $15.1M | 2.18% |
135,800
+92,676
|
|
||
16
Vir Biotechnology
VIR
$1.61B
| $13.4M | 1.94% |
1,498,620
+1,020,277
|
|
||
17
Haemonetics
HAE
$3.08B
| $12.4M | 1.79% |
220,672
+128,041
|
|
||
|
SION
18
Sionna Therapeutics
SION
$1.93B
| $11.8M | 1.7% |
+294,340
|
|
||
19
Sanofi
SNY
$105B
| $11.5M | 1.66% |
239,671
-732,015
|
|
||
|
RAPP
20
Rapport Therapeutics
RAPP
$1.89B
| $11.5M | 1.65% |
366,809
+181,544
|
|
||
21
Teleflex
TFX
$5.69B
| $11.3M | 1.63% |
94,800
+7,924
|
|
||
22
BioMarin Pharmaceuticals
BMRN
$11.1B
| $11M | 1.58% |
194,226
-38,462
|
|
||
23
Cross Country Healthcare
CCRN
$406M
| $10.3M | 1.49% |
1,098,393
+29,572
|
|
||
24
Protara Therapeutics
TARA
$261M
| $10.3M | 1.48% |
1,969,839
+254,445
|
|
||
25
Structure Therapeutics
GPCR
$2.8B
| $10.1M | 1.45% |
209,093
+7,593
|
|